• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Biomedical and Pharmaceutical Sciences
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 8 (2025)
Volume Volume 7 (2024)
Volume Volume 6 (2023)
Volume Volume 5 (2022)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 4 (2021)
Volume Volume 3 (2020)
Volume Volume 2 (2019)
Volume Volume 1 (2018)
Ghoname, R., Ghozlan, H., Sabry, S. (2022). Novel research on Rapamycin analogue production by Streptomyces sp. strain RHS5. Journal of Advanced Biomedical and Pharmaceutical Sciences, 5(2), 88-95. doi: 10.21608/jabps.2022.106306.1144
Reham Mohammad Ghoname; Hanan Adly Ghozlan; Soraya Abd el Fattah Sabry. "Novel research on Rapamycin analogue production by Streptomyces sp. strain RHS5". Journal of Advanced Biomedical and Pharmaceutical Sciences, 5, 2, 2022, 88-95. doi: 10.21608/jabps.2022.106306.1144
Ghoname, R., Ghozlan, H., Sabry, S. (2022). 'Novel research on Rapamycin analogue production by Streptomyces sp. strain RHS5', Journal of Advanced Biomedical and Pharmaceutical Sciences, 5(2), pp. 88-95. doi: 10.21608/jabps.2022.106306.1144
Ghoname, R., Ghozlan, H., Sabry, S. Novel research on Rapamycin analogue production by Streptomyces sp. strain RHS5. Journal of Advanced Biomedical and Pharmaceutical Sciences, 2022; 5(2): 88-95. doi: 10.21608/jabps.2022.106306.1144

Novel research on Rapamycin analogue production by Streptomyces sp. strain RHS5

Article 4, Volume 5, Issue 2, April 2022, Page 88-95  XML PDF (620.92 K)
Document Type: Original Article
DOI: 10.21608/jabps.2022.106306.1144
View on SCiNiTO View on SCiNiTO
Authors
Reham Mohammad Ghoname email orcid 1; Hanan Adly Ghozlan2; Soraya Abd el Fattah Sabry3
1researcher at microbiology,Faculty of Science,Alexandria university
2Professor at microbiology,Faculty of Science,Alexandria university
3Professor at Faculty of Science ,Alexandria University
Abstract
Rapamycin (Rap), as a macrocyclic polyketide with immune suppressive, antifungal, and anti-tumor activity produced by Streptomyces hygroscopicus, is receiving considerable attention for its significant contribution in medical field. However, the production capacity of the wild strain is very low. Due to the high price of rapamycin drug (1MG 30/TAB price= 900PT) and the limited number of producing organisms, the present research was conducted to search for novel strains from local environments capable of producing rapamycin. Streptomyces sp. RHS5 selected from thirty-three actinobacterial isolates was the most potent in producing the active metabolite and was compared with rapamycin produced by Streptomyces hygroscopicus using bioautography. The chemical structure of the purified compound determined by spectroscopic analyses was found to be analogue to rapamycin. So far, considerable efforts have been made to improve rapamycin production, such as fermentation technology optimization. In this research, the production of rapamycin analogue was economically achieved by applying the solid-state fermentation (SSF) using wheat bran as a substrate and optimization of culture condition was achieved by the statistical design Plackett- Burman. The productivity of rapamycin analogue after optimization increased by 1.18 fold compared to basal medium.
Keywords
Streptomyces sp. RHS5; Rapamycin; Solid state fermentation; Statistical optimization
Main Subjects
Microbiology
Statistics
Article View: 417
PDF Download: 541
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.